VanEck Social Sentiment ETF (BUZZ) Stock Price, News & Analysis

Company Overview

Pharmadrug Inc. operates as a specialty pharmaceutical company. It focuses on the research, development, and commercialization of controlled-substances and natural medicines, such as psychedelics, cannabis, and naturally-derived approved drugs. It also distributes medical cannabis to pharmacies in Germany and rest of the European Union; and owns and operates in the psychedelic smartshop market. In addition, the company engages in the adult use psychedelic retail business; and researching and reformulating established natural medicines. It has a research agreement with the University of Michigan to evaluate N, N-dimethyltryptamine's (DMT) potential role in normal, diseased, and altered states of consciousness, as well as an agreement with Southwest Research Institute for initiating non-clinical and clinical manufacturing of Cepharanthine. The company was formerly known as Aura Health Inc. and changed its name to Pharmadrug Inc. in October 2019. The company is based in Toronto, Canada.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BUZZ Stock Analysis - Frequently Asked Questions

How do I buy shares of VanEck Social Sentiment ETF?

Shares of BUZZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of VanEck Social Sentiment ETF own?

Based on aggregate information from My MarketBeat watchlists, some other companies that VanEck Social Sentiment ETF investors own include Taiwan Semiconductor Manufacturing (TSM), Ford Motor (F), Pfizer (PFE), Akamai Technologies (AKAM), Viemed Healthcare (VMD), Verizon Communications (VZ) and Advanced Micro Devices (AMD).

Industry, Sector and Symbol

• Stock Exchange: CNSX
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: CNSX:BUZZ
• CUSIP: N/A
• CIK: N/A
• Web: www.pharmadrug.co
• Phone: 647 202 1824
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A